Issue link: https://www.e-digitaleditions.com/i/1544305
This is the latest in a series of updates featured in Inhalation that highlights previous, current and future activities of the Association of Inhalation Toxicologists (AIT). The primary aim/objective of the AIT is “to promote and develop the field of inhalation toxicology, via open discussion, exchange of ideas and information, and presentation of high-quality scientific research.” 8 April 2026 Inhalation CROSS-INDUSTRY Organizations An update from the Association of Inhalation Toxicologists (AIT) Jo Kilgour, PhD and Charlie Knill, PhD is is the latest in a series of updates featured in Inhalation that highlights previous, current and future activities of the Association of Inhalation Toxicologists (AIT). An introduction to the AIT e primary aim/objective of the AIT is "to promote and develop the field of inhalation toxicology, via open discussion, exchange of ideas and information, and presentation of high-quality scientific research." is is achieved by organization of an annual international confer- ence, publication of research arti- cles, creation and management of "workstreams" and presentation of virtual webinars/courses. Engage- ment with the wider inhalation toxicology community, such as sharing information and the lat- est advances, is achieved by a reg- ularly updated online presence, via the AIT website and LinkedIn group (which currently has more than 240 members): www.aitoxic ology.org and www.linkedin.com/ groups/13654177. Attendees from varied back- grounds reflect the diversity of people with a shared interest in the specialized aspects of the prac- tice and interpretation of inhala- tion toxicology studies. e AIT is also seen as an excellent training ground for individuals beginning a career in this field. To that end, we have recently increased oppor- tunities for students to attend our conferences, with lower registra- tion fees, poster prizes and student presentation sessions. The AIT's history e AIT was founded in the 1970's in the United Kingdom. Its first conference was held in 1981 and the organization grew in size and reputation over subsequent years, becoming an international group. e AIT committee includes rep- resentatives from the UK, Europe and North America. e AIT has also formed strong connections with other organizations, such as the International Society of Aero- sols in Medicine (ISAM), the British Society of Toxicological Pathology (BSTP), Drug Delivery to the Lungs (DDL) and the British Toxicology Society (BTS). ese links have resulted in a number of joint conferences/publications; and currently we are working to deliver an inhalation toxicology course (including webinars and an in-person event) for the BTS Skills Gap Initiative: www.thebts. org/skills-gap-initiative/. Past annual conferences Locations for the annual confer- ence rotate among the UK, North America and Europe to facilitate ease of travel for attendees. A list of previous conferences (and webi- nars delivered during COVID) can be found on our website. A brief overview of the last three conferences is shown here: Spring 2023, Gothenburg, Sweden—"Spring is in the Air" Topics included in vitro exposure systems, anatomical and physio- logical parameters for the respi- ratory tract across life, inhaled cannabinoids, and general updates inclusive of primate inhala- tion methods. Delegates had the opportunity to tour AstraZeneca's inhalation facilities. Autumn 2024, Cleveland, Ohio, US—"Inhalation Toxicology Rocks" Topics included new assessment methods (NAMs) and improving translation of in vitro assays, inha- lation modalities and mitigations, intranasal delivery, generation, characterization and sampling of aerosols, estimating safe human doses, and wildfires and inhalation health risks. Delegates were able to visit the Charles River Laborato- ries Ashland inhalation facility. Spring 2025, Milton Keynes, UK—"Inhalation Trailblazers" Topics included the EU-funded HARMLESS project, NAMs, e- cigarettes, organoids, microphys- iological systems, and AI predictive toxicology. ere was also a visit to ImmuOne's Stevenage facility and a practical inhalation session hosted by Labcorp. Poster prizes (student and non-student) were awarded for the first time, sponsored by Frontiers in Toxicology (FiT). 2026 annual conference Planning is underway for the 2026 annual conference, which will be held September 22-24 in Madrid, Spain. Attendees will have the opportunity to visit Vivotecnia's facilities. Student and non- student poster prizes will be presented. See the AIT website and LinkedIn page for updates. e 2027 conference will take place in North America.

